UNFO, OrthoPediatrics Bring Newborn Foot Brace to U.S. Market

UNFO Med Ltd. has partnered with OrthoPediatrics to bring its U.S. Food and Drug Administration-registered corrective foot brace for metatarsus adductus (MTA) to the United States. The condition affects approximately 5% of newborns, causing the front of the foot to turn inward.

The Universal Neonatal Foot Orthotics (UNFO) system is the first non-invasive alternative to casting and surgery for this condition.

Metatarsus adductus—also known as metatarsus varus—is a congenital foot condition caused by misalignment at the midfoot’s tarsometatarsal joints. When one sibling has this genetic condition, the likelihood increases to 12% for subsequent children. Without treatment, affected kids face increased risk of foot deformities, chronic pain, and gait problems that can cause frequent falls.

For decades, casting and surgical intervention have been the only treatment options for MTA in infants. Traditional casting causes significant discomfort and distress for both infants and parents, often requiring multiple applications over several months.

UNFO’s corrective foot brace, developed by pediatric orthopedic specialist (and UNFO Med Ltd. CEO) Dr. Izak Daizade, eliminates this painful process entirely, according to the company. After spending 30 years treating newborns and 10 years on focused research, Dr. Daizade created UNFO—a short orthotic device worn below the ankle that addresses the three-dimensional anatomic deformities in infants’ foot structures. The discreet, sandal-like design provides effective correction while ensuring gentle, comfortable care. Dr. Daizade has successfully treated more than 15,000 patients with a 95% success rate.

“By partnering with OrthoPediatrics, we’re bringing UNFO to families across the U.S., transforming care for newborns with Metatarsus Adductus,” Dr. Daizade said. “This represents more than a technological advancement—it’s a fundamental shift toward proactive, compassionate pediatric orthopedic care that spares infants unnecessary pain and trauma.”

UNFO’s patented foot brace is currently available to U.S. medical practitioners and orthopedic specialists.

UNFO Med Ltd. is striving to reshape early childhood healthcare by revolutionizing treatment methodologies and crafting solutions for prevalent orthopedic conditions in infants and children. The UNFO system was developed collaboratively with medical experts, including a renowned Israeli pediatric orthopedic specialist.

Founded in 2006, OrthoPediatrics is focused exclusively on advancing pediatric orthopedics. As such, it has developed a comprehensive product offering to the pediatric orthopedic market. OrthoPediatrics currently markets more than 85 products that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and more than 75 countries outside the United States.